Newly diagnosed? Read the latest insights on what to expect next.
-
-
Educate, motivate, advocate: The media’s potential in the rare disease space
-
What living with a chronic illness has taught me
-
Eplontersen falls short in major ATTR-CM study
-
New study sheds light on patients’ experiences in ATTR care
-
CRT linked to better survival in patients with advanced ATTR-CM
-
Serum transthyretin levels may predict tafamidis therapy outcomes in ATTR-CM